2018
The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats
Costa G, Serra M, Pintori N, Casu M, Zanda M, Murtas D, De Luca M, Simola N, Fattore L. The novel psychoactive substance methoxetamine induces persistent behavioral abnormalities and neurotoxicity in rats. Neuropharmacology 2018, 144: 219-232. PMID: 30366005, DOI: 10.1016/j.neuropharm.2018.10.031.Peer-Reviewed Original ResearchConceptsEffects of methoxetamineElevated plus mazePersistent behavioral abnormalitiesBehavioral effectsPlus mazeLocomotor activityBehavioral abnormalitiesDensity of dopamine transportersLocomotor activity of ratsImpaired non-spatial memoryNovel object recognition testEmission of ultrasonic vocalizationsMedial prefrontal cortexMarble burying testVentral tegmental areaPersistent behavioral effectsNon-spatial memoryNovel object recognitionObject recognition testActivity of ratsNeurotoxic effectsSubstantia nigra pars compactaSerotonergic damageNucleus accumbensBurying test
2016
Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects
Zanda M, Fadda P, Chiamulera C, Fratta W, Fattore L. Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects. Behavioural Pharmacology 2016, 27: 489-496. PMID: 27128862, DOI: 10.1097/fbp.0000000000000241.Peer-Reviewed Original ResearchConceptsEffects of methoxetamineN-methyl-d-aspartate receptor antagonistic propertiesPsychoactive substancesReceptor antagonist propertiesOccurrence of adverse effectsAdverse pharmacological effectsDopamine neurotransmissionMesolimbic pathwayAntidepressant activityPreclinical dataPreclinical findingsAntagonistic propertiesLong-term effectsPharmacological effectsStimulatory effectMethoxetamineAdverse effectsKetamineLegal highsResearch chemicalsToxicological effectsPhencyclidineDopamineNeurotransmissionIncreasing number